Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.
Berger S, Procko E, Margineantu D, Lee EF, Shen BW, Zelter A, Silva DA, Chawla K, Herold MJ, Garnier JM, Johnson R, MacCoss MJ, Lessene G, Davis TN, Stayton PS, Stoddard BL, Fairlie WD, Hockenbery DM, Baker D.
Berger S, et al. Among authors: procko e.
Elife. 2016 Nov 2;5:e20352. doi: 10.7554/eLife.20352.
Elife. 2016.
PMID: 27805565
Free PMC article.